Urgent.News

What's breaking now, across thousands of outlets.

Business

Abbott to Pay $385 Million to End Claims Over Infant Formula

Abbott Laboratories agreed to pay $385 million to settle U.S. allegations related to poor manufacturing practices at two facilities, including one involving an investigation of a contaminated facility that made powder infant formula. The accord resolves claims that the company …

Abbott to Pay $385 Million to End Claims Over Infant Formula

We haven't written up this one. Insurance Journal has the full story — the link below goes straight to it.

Read the original at insurancejournal.com →

More in Business

ESG is becoming a license to operate

ESG is moving beyond reputation and disclosure. For businesses operating in increasingly scrutinised environments, responsible practices are becoming essential to read more ESG is becoming a license…

More from Wednesday 16 September →